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Oxidants are thought to damage cells, and stemcells are viewed as particularly vulnerable to oxidative stress.
Now, a new study (Morimoto et al., 2013) suggests that the self-renewal of certain stem cells may actually
require reactive oxygen species (ROS).It wouldn’t be surprising if people inter-
ested in the physiology of reactive oxygen
species (ROS) felt a certain kinship with
Miles Monroe. As some may recall, Miles
Monroe is the name of Woody Allen’s
character in the classic comedy Sleeper
(1973). In the movie, Allen plays the
neurotic owner of the ‘‘Happy Carrot’’
health food store who is cryogenically
frozen without his consent. Awakened
two hundred years later, he finds that
his old breakfast of wheat germ, organic
honey, and tiger’s milk has been replaced
with what science has now established
as the far healthier alternatives: deep fat,
steak, and cream pies. As the futuristic
scientists in the movie explain, those
20th century notions of what was thought
to be unhealthy are ‘‘precisely the oppo-
site of what we now know to be true.’’
A ‘‘precisely the opposite’’ result can
occasionally happen in science, the latest
example of which can be found in a fasci-
nating new manuscript by Morimoto et al.
(2013) recently published inCell StemCell.
In this manuscript, the authors demon-
strate that, rather than being harmful,
ROS are in fact required for spermatogo-
nial stem cell (SSC) self-renewal (Mori-
moto et al., 2013). This study must be
viewed in the context of the relatively
recent and rather tumultuous evolution of
what is understood about how ROS
function in cells. Long viewed as merely
toxic byproducts of aerobic respiration,
the perception of ROS began to change
when oxidants were demonstrated to be
purposely produced by cells in response
to growth factor stimulation and seem-
ingly necessary for downstream signaling
(Sundaresan et al., 1995). In many cases,
the enzymatic source of ROS production
was not the mitochondria but instead the
NOX family of widely expressed NADPH
oxidases (Lambeth, 2004). This family
of oxidases was first described in phago-cytic cells, where they generate ROS for
host defense and their activity is regulated
by the Ras superfamily of small GTPases.
A similar regulatory role for the Ras family
of small GTPase is also evident for ROS
production in nonphagocytic cells (Sun-
daresan et al., 1996).
While these studies seemed to partially
rehabilitate the reputation of ROS, other
work seemed to solidify their toxic nature.
This was particularly evident when it came
to the biology of stem cells. Predomi-
nantly analyzing the hematopoietic stem
cell (HSC) system, various genetic models
(including deletion of the ATM protein
kinase), knockout of transcription factors
(such as Prdm16 or members of the
FoxO family), or removal of epigenetic
factors (such as Bmi1), all demonstrated
that an increase in stem cell ROS levels
resulted in a subsequent impairment in
various stem cell properties, including a
profound reduction in self-renewal capac-
ity (Wang et al., 2013). Thus, it seemed
clear that the unique capacity of stem
cells to divide and give rise to new stem
cells (e.g., self-renew) appeared exqui-
sitely sensitive to a rise in ROS levels.
In this context, the new result of
Morimoto et al. (2013) further upends
what we thought we knew about ROS
and stem cell self-renewal. The system
they analyzed involved SSCs, cells that
undergo continuous self-renewal in the
male testis in order to produce a contin-
uous supply of spermatozoa. Previous
studies had demonstrated that male
germline cells could be cultured in vitro
with the aid of factors such as glial cell
line-derived neurotrophic factor (GDNF)
and fibroblast growth factor 2 (FGF2),
proteins normally secreted by supporting
Sertoli cells (Kanatsu-Shinohara et al.,
2003). Furthermore, these investigators
had shown that germline cells could be
maintained in a cytokine-free environmentCell Metabowhen they were engineered to express a
constitutively activated form of the Ras
GTPase (Lee et al., 2009). These Ras-
transduced cells appeared to bypass the
need for trophic factors anddemonstrated
long-term self-renewal capacity.
The current study sought to address
what might be downstream of Ras that
mediates SSC self-renewal. One clue
that Morimoto et al. (2013) pursued in
this recent study was that stimulation
of germline cells with FGF2 or GDNF
appeared to result in increased ROS
levels. Moreover, pharmacological treat-
ment with antioxidants or using various
chemical inhibitors of the NOX enzymes
appeared to reduce the in vitro and
in vivo self-renewal capacity of SSCs.
In contrast, supplementing germline
cultures with low, continuous levels of
exogenous hydrogen peroxide appeared
to substantially increase the number
of SSCs. Taken together, these results
suggest that NOX-generated hydrogen
peroxide was a necessary requirement
for effective self-renewal in SSCs. This
point was further emphasized when
the authors demonstrated that Nox1-
deficient SSCs had a self-renewal deficit
that was particularly evident after serial
transplantation into recipient testis.
How can we make sense of these latest
results, which seem to argue that ROS
are surprisingly required for SSC self-
renewal? In particular, how does this
new result fit in with multiple previous
sets of observations suggesting that a
rise in ROS is clearly detrimental to stem
cell self-renewal capacity? One simple
explanation may be that the current study
employing SSCs and the past studies
employing predominantly HSCs represent
observations of different stem cells with
different sets of biological requirements.
Perhaps more appealing is the issue
of degree. Clearly, high, continuous, andlism 18, July 2, 2013 ª2013 Elsevier Inc. 1
Figure 1. ROS and Stem Cell Self-Renewal
Genetic and pharmacological interventions can raise or lower ROS levels in stem cells. Previous studies
have established that increasing ROS levels within stem cells impairs self-renewal capacity. A new report
suggests that lowering ROS levels can also be detrimental.
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Previewsunregulated levels of ROS appear bad for
stem cells. That point was evident in the
current study, since when high, rather
than low, amounts of hydrogen peroxide
levels were used, SSC self-renewal was
indeed impaired. In contrast, the current
manuscript would argue that reducing
ROS too much can also be harmful.
Thus, redox homeostasis in stem cells
follows what might be called the Goldi-
locks rule that requires ROS levels to be
not too high, not too low, but just right to
maintain functional integrity (Figure 1).2 Cell Metabolism 18, July 2, 2013 ª2013 ElsPerhaps these results should not come
as a complete surprise. For instance,
while most observations are consistent
with a detrimental effect for ROS, at least
one previous study showed that reducing
ROS levels too much inhibited the self-
renewal capacity of neural stem cells (Le
Belle et al., 2011). Similarly, studies in
Drosophila suggest that in certain he-
matopoietic progenitors, increased ROS
levels act as a brake that blocks differen-
tiation of these immature progenitor cells
into more mature cell types (Owusu-evier Inc.Ansah and Banerjee, 2009). Thus,
whether ROS are good or bad and
whether they act as an inhibitor or pro-
moter for stemness and self-renewal
seems to be still open for debate.
Now, if we could only reopen the debate
between wheat germ and cream pies.REFERENCES
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